by MM360 Staff | Jun 10, 2021 | Uncategorized
(Cardinal Health) June 10, 2021 – The new indication will provide accurate and precise lymph node identification in pediatric patients one month and older with melanoma, rhabdomyosarcoma or other types of solid tumors.
by MM360 Staff | Jun 10, 2021 | Uncategorized
(Yahoo! Finance) June 10, 2021 – VERU-100 formulated to address the clinical limitations of currently available androgen deprivation therapy. The Phase 2 clinical trial is expected to be completed by 2H calendar 2021.
by MM360 Staff | Jun 10, 2021 | Uncategorized
(Washington Post) June 9, 2021 – Two members of a Food and Drug Administration advisory panel resigned this week after the agency’s contentious decision to approve an Alzheimer’s drug over the objections of its outside advisers.
by MM360 Staff | Jun 10, 2021 | Uncategorized
(STAT) June 10, 2021 – Saying structural racism is a chronic problem throughout biomedical research and within their own walls, leaders of the National Institutes of Health Thursday unveiled a plan intended to eliminate a big gap in grants awarded to white and...
by MM360 Staff | Jun 10, 2021 | Uncategorized
(Kaiser Health News) June 10, 2021 – Dr. John Carlo is concerned that patients at Prism Health North Texas who rely on the health care safety net will soon be struggling even more to stay on PrEP, a medication that prevents HIV transmission.
by MM360 Staff | Mar 23, 2021 | Featured News, Myeloma News, Uncategorized
A lot of progress has been made in myeloma, but there remains unmet need of patients who’ve exhausted many treatment options. In a new prospective, prospective, multicenter, single-arm clinical trial study published in Nature Medicine, the researchers used...
